Koortslipcrème Aciclovir Albert Heijn

Aciclovir, the active ingredient in Koortslipcrème Aciclovir Albert Heijn, is an antiviral presented as a topical cream for topical use. It treats herpes labialis (cold sores) in adults and children.

GNH USA supplies Koortslipcrème Aciclovir Albert Heijn as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Aciclovir is an antiviral agent that inhibits replication of herpes simplex virus.

- Herpes labialis (cold sores): shortens healing time and eases pain. - Recurrent oral herpes: reduces frequency and severity of outbreaks. - Primary oral herpes infection: limits lesion development and viral shedding.

Topical aciclovir may cause local skin reactions.

Common Side Effects: - Mild burning or stinging at the application site. - Itching or mild irritation. - Redness or erythema. - Dryness or peeling of the skin. - Tingling sensation. - Minor rash.

Serious or Rare Side Effects: - Allergic contact dermatitis. - Severe skin rash or exfoliative dermatitis. - Swelling of the face, lips, or tongue. - Blistering or ulceration of the treated area. - Anaphylactic reaction (rare). - Persistent or worsening irritation requiring medical attention.

When using Koortslipcrème Aciclovir Albert Heijn, follow these safety measures.

- Apply only to intact skin: avoid broken skin or mucous membranes. - Do not use near the eyes: keep the product away from ocular surfaces. - Use with caution in infants under 12 months unless directed by a healthcare professional. - Consult a healthcare professional if you are pregnant or breastfeeding. - Discontinue use and seek medical advice if severe irritation or allergic reaction occurs. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Topical aciclovir has limited systemic interactions, but certain combinations may affect safety or efficacy.

Major Interactions (Avoid): - Concurrent use of other topical antiviral agents: may increase local irritation. - Use with systemic immunosuppressants: may reduce antiviral efficacy. - Application of multiple topical medications on the same area: risk of additive skin irritation.

Moderate Interactions (Monitor Closely): - Co‑application with topical corticosteroids: may mask signs of infection. - Use with skin sensitizers or fragrances: monitor for heightened irritation. - Combination with over‑the‑counter skin products (e.g., moisturizers, acne treatments): assess compatibility and watch for adverse skin reactions.